Cargando…

COVID-19—A Theory of Autoimmunity Against ACE-2 Explained

The COVID-19 pandemic caused by the coronavirus SARS-COV-2 has cost many lives worldwide. In dealing with affected patients, the physician is faced with a very unusual pattern of organ damage that is not easily explained on the basis of prior knowledge of viral-induced pathogenesis. It is establishe...

Descripción completa

Detalles Bibliográficos
Autores principales:	McMillan, Philip, Dexhiemer, Thomas, Neubig, Richard R., Uhal, Bruce D.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2021
Materias:	Immunology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8021777/ https://www.ncbi.nlm.nih.gov/pubmed/33833750 http://dx.doi.org/10.3389/fimmu.2021.582166

Ejemplares similares

ACE2, Much More Than Just a Receptor for SARS-COV-2
por: Samavati, Lobelia, et al.
Publicado: (2020)

ACE and ACE2 Gene Variants Are Associated With Severe Outcomes of COVID-19 in Men
por: Martínez-Gómez, Laura E., et al.
Publicado: (2022)

Angiotensin Converting Enzyme-2 (ACE-2) role in disease and future in research
por: Abdul-Hafez, Amal, et al.
Publicado: (2021)

Regulation of ACE-2 enzyme by hyperoxia in lung epithelial cells by post-translational modification
por: Mohamed, Tarek, et al.
Publicado: (2021)

Autoimmune Theories of Chronic Spontaneous Urticaria
por: Bracken, Sonali J., et al.
Publicado: (2019)

COVID-19: Infection or Autoimmunity
por: Icenogle, Timothy
Publicado: (2020)

ACE2 Serum Levels as Predictor of Infectability and Outcome in COVID-19
por: Maza, María del Carmen, et al.
Publicado: (2022)

Expression of ACE2, Soluble ACE2, Angiotensin I, Angiotensin II and Angiotensin-(1-7) Is Modulated in COVID-19 Patients
por: Osman, Ikram Omar, et al.
Publicado: (2021)

Angiotensin-Converting Enzyme 2 (ACE2) in the Pathogenesis of ARDS in COVID-19
por: Kuba, Keiji, et al.
Publicado: (2021)

Autoimmunity against laminin 332
por: Patzelt, Sabrina, et al.
Publicado: (2023)

ACE/ACE2 balance might be instrumental to explain the certain comorbidities leading to severe COVID-19 cases
por: Bank, Sarbashri, et al.
Publicado: (2021)

Lymphopenia-Induced Proliferation in Aire-Deficient Mice Helps to Explain Their Autoimmunity and Differences from Human Patients
por: Kisand, Kai, et al.
Publicado: (2014)

Autoimmune hepatitis after COVID-19 vaccination
por: Zheng, Han, et al.
Publicado: (2022)

Autoantibodies Against Proteins Previously Associated With Autoimmunity in Adult and Pediatric Patients With COVID-19 and Children With MIS-C
por: Burbelo, Peter D., et al.
Publicado: (2022)

Regulated Intramembrane Proteolysis of ACE2: A Potential Mechanism Contributing to COVID-19 Pathogenesis?
por: Gonzalez, Sandra M., et al.
Publicado: (2021)

Men more vulnerable to COVID-19: explained by ACE2 on the X chromosome?
por: Sama, Iziah E, et al.
Publicado: (2020)

Impact of Autoantibodies against Glycolytic Enzymes on Pathogenicity of Autoimmune Retinopathy and Other Autoimmune Disorders
por: Adamus, Grazyna
Publicado: (2017)

ACE2/ADAM17/TMPRSS2 Interplay May Be the Main Risk Factor for COVID-19
por: Zipeto, Donato, et al.
Publicado: (2020)

Absolving COVID-19 Vaccination of Autoimmune Bullous Disease Onset
por: Russo, Roberto, et al.
Publicado: (2022)

Autoimmune Skin Disease Exacerbations Following COVID-19 Vaccination
por: Sprow, Grant, et al.
Publicado: (2022)

Co-Expression of Mitochondrial Genes and ACE2 in Cornea Involved in COVID-19
por: Yuan, Jian, et al.
Publicado: (2020)

Host Genetics at the Intersection of Autoimmunity and COVID-19: A Potential Key for Heterogeneous COVID-19 Severity
por: Karaderi, Tugce, et al.
Publicado: (2020)

The Efficacy of Cancer Immunotherapies Is Compromised by Helicobacter pylori Infection
por: Oster, Paul, et al.
Publicado: (2022)

Novel ACE2 fusion protein with adapting activity against SARS-CoV-2 variants in vitro
por: Zekri, Latifa, et al.
Publicado: (2023)

Game Theory in International Economics
por: McMillan, J
Publicado: (2013)

Autoimmunity to ACE2 as a possible cause of tissue inflammation in Covid-19
por: Townsend, Alain
Publicado: (2020)

ACE2 mutation might explain lower COVID-19 burden in malaria endemic areas
por: De, Auley, et al.
Publicado: (2021)

COVID-19 in Association With Development, Course, and Treatment of Systemic Autoimmune Rheumatic Diseases
por: Lakota, Katja, et al.
Publicado: (2021)

Autoimmune and Rheumatic Manifestations Associated With COVID-19 in Adults: An Updated Systematic Review
por: Tang, Kuo-Tung, et al.
Publicado: (2021)

Autoimmune Neuromuscular Disorders in Childhood
por: McMillan, Hugh J., et al.
Publicado: (2011)

Design of a chimeric ACE-2/Fc-silent fusion protein with ultrahigh affinity and neutralizing capacity for SARS-CoV-2 variants
por: Bodie, Neil M, et al.
Publicado: (2023)

Explainable Brain Age Prediction using coVariance Neural Networks
por: Sihag, Saurabh, et al.
Publicado: (2023)

Egg-Derived Anti-SARS-CoV-2 Immunoglobulin Y (IgY) With Broad Variant Activity as Intranasal Prophylaxis Against COVID-19
por: Frumkin, Lyn R., et al.
Publicado: (2022)

Autoimmunity (or Not) in Atopic Dermatitis
por: Roesner, Lennart M., et al.
Publicado: (2019)

Involvement of Acetylcholine Receptors in Cholinergic Pathway-Mediated Protection Against Autoimmune Diabetes
por: Fernández-Cabezudo, Maria J., et al.
Publicado: (2019)

COVID-19: Acing the Treatment
por: Hunter, Jez, et al.
Publicado: (2022)

DNA immunization with in silico predicted T-cell epitopes protects against lethal SARS-CoV-2 infection in K18-hACE2 mice
por: Persson, Gry, et al.
Publicado: (2023)

Autoantibodies against Neurologic Antigens in Nonneurologic Autoimmunity
por: Stathopoulos, Panos, et al.
Publicado: (2019)

Engineered soluble ACE2 receptor: Responding to change with change
por: Li, Guangyao, et al.
Publicado: (2023)

Siglec-E Promotes β2-Integrin-dependent NADPH Oxidase Activation to Suppress Neutrophil Recruitment to the Lung
por: McMillan, Sarah J., et al.
Publicado: (2014)

Cannot write session to /tmp/vufind_sessions/sess_c0etvm51p7t3eldofu5g4loo4b